Guided Therapeutics (GTHP) Asset Utilization Ratio (2016 - 2025)
Guided Therapeutics (GTHP) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.69 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio rose 12825.2% to 0.69 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69 through Dec 2025, up 12825.2% year-over-year, with the annual reading at 0.57 for FY2025, 12256.19% up from the prior year.
- Asset Utilization Ratio hit 0.69 in Q4 2025 for Guided Therapeutics, up from 0.19 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q4 2025 to a low of 0.0 in Q1 2025.
- Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.04 in 2022.
- Biggest YoY gain for Asset Utilization Ratio was 12825.2% in 2025; the steepest drop was 98.36% in 2025.
- Year by year, Asset Utilization Ratio stood at 0.04 in 2021, then tumbled by 91.61% to 0.0 in 2022, then skyrocketed by 1438.52% to 0.06 in 2023, then plummeted by 90.36% to 0.01 in 2024, then soared by 12825.2% to 0.69 in 2025.
- Business Quant data shows Asset Utilization Ratio for GTHP at 0.69 in Q4 2025, 0.19 in Q3 2025, and 0.12 in Q2 2025.